Darbepoetin was well tolerated and conveniently coordinated with cyclic chemotherapy. Ten patients maintained a hemoglobin concentration of ≥11 g/dL for at least two treatment periods.

Purpose: The effectiveness of every-three-week administration of darbepoetin alfa in women with chemotherapy-associated anemia was evaluated. Methods: Women receiving chemotherapy for ...